Literature DB >> 1106846

5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.

D C Stolinsky, R P Pugh, J R Bateman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1106846

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  4 in total

1.  Chemotherapy of pancreatic carcinoma.

Authors:  J H Harvey; P S Schein
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

Review 2.  The practical benefits of pharmacokinetics in the use of antineoplastic agents.

Authors:  C Erlichman; R C Donehower; B A Chabner
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 3.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

4.  The influence of cimetidine on the pharmacokinetics of 5-fluorouracil.

Authors:  V J Harvey; M L Slevin; M R Dilloway; P I Clark; A Johnston; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.